LOGIN

phase 3-trials

US to procure 1.7 million courses of molnupiravir coronavirus pills

US to procure 1.7 million courses of molnupiravir coronavirus pills

World
Bharat Biotech's Covaxin found 81% efficient in Phase 3 trials

Bharat Biotech's Covaxin found 81% efficient in Phase 3 trials

India News
Developers say Sputnik V likely to give 2 years Covid-19 immunity, Pfizer 4-5 months

Developers say Sputnik V likely to give 2 years Covid-19 immunity, Pfizer 4-5 months

World